MD, Ph.D., Chairman, and CEO of Umecrine AB, also serves as Chief Scientific Officer and Medical Director in Umecrine Mood and Umecrine Cognition. Torbjörn Bäckström is currently a part-time professor at the Department of Clinical Science, Obstetrics and Gynecology, Umeå University. He is also a manager of the Umeå Neurosteroid Research Center. Torbjörn Bäckström's main focus of research since 1972 is the effect of sex and stress hormones on the brain and conditions induced by these hormones, he has more than 400 scientific publications within this area and he is a frequently invited key-note speaker at scientific congresses around the world. From 1989 to 1995 Torbjörn Bäckström served at the scientific board of the company, CoCensys Inc., Irvine CA, USA, based on his own research and the research of Professor Kelvin Gee, University of California. Several active substances were developed and one of those is currently in phase III of clinical assessment. CoCensys, with approximately 120 employees, was listed on the NASDAQ stock market until 1998 when it was sold to a larger pharmaceutical company.